Marine pharmacology in 2018: Marine compounds with antibacterial, antidiabetic, antifungal, anti-inflammatory, antiprotozoal, antituberculosis and antiviral activities; affecting the immune and nervous systems, and other miscellaneous mechanisms of action

• Egile Nagusiak: Alejandro M.S. Mayer (Egilea), Marsha L. Pierce (Egilea), Katelyn Howe (Egilea), Abimael D. Rodríguez (Egilea), Orazio Taglialatela-Scafati (Egilea), Fumiaki Nakamura (Egilea), Nobuhiro Fusetani (Egilea)
• Formatua: Liburua
• Argitaratua: Elsevier, 2022-09-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

The 2018 marine pharmacology literature review represents a continuation of the previous 11 reviews of a series initiated in 1998. Preclinical marine pharmacology research during 2018 was performed by investigators in 44 countries and contributed novel pharmacology for 195 marine compounds. The peer...